Page last updated: 2024-08-21

hematoxylin and pioglitazone

hematoxylin has been researched along with pioglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, C; Zhang, D; Zhang, H; Zhu, Y	1

Other Studies

1 other study(ies) available for hematoxylin and pioglitazone

Article	Year
Pioglitazone Protects Against Hypoxia-Induced Cardiomyocyte Apoptosis Through Inhibiting NLRP3/Caspase-1 Pathway in vivo and in vitro. International heart journal, 2022, Sep-30, Volume: 63, Issue:5 Topics: Apoptosis; Caspase 1; Creatine Kinase; Cytochromes c; Eosine Yellowish-(YS); Hematoxylin; Humans; Hypoxia; Lactate Dehydrogenases; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pioglitazone; Superoxide Dismutase	2022

Article

Year

Pioglitazone Protects Against Hypoxia-Induced Cardiomyocyte Apoptosis Through Inhibiting NLRP3/Caspase-1 Pathway in vivo and in vitro.

International heart journal, 2022, Sep-30, Volume: 63, Issue:5

Topics: Apoptosis; Caspase 1; Creatine Kinase; Cytochromes c; Eosine Yellowish-(YS); Hematoxylin; Humans; Hypoxia; Lactate Dehydrogenases; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pioglitazone; Superoxide Dismutase

2022